- TcLand Expression will receive 1.2 million Euros from Oseo and ERDF to support a leading project in personalised medicine focused on Rheumatoid Arthritis
- TcLand Expression’s board of directors appoints highly qualified personalized medicine expert Felix Frueh PhD, as new board member
- TcLand Expression is part of the Innovative Medicines Initiative “Be The CURE”, the largest European consortium for Rheumatology
- TcLand Expression launches the “PRINT” international clinical trial to validate its blood biomarker RA-INF-Dx and announces the recruitment of its first patient
- TcLand Expression nominated as a featured member of the US Personalized Medicine Coalition
Category Archives: Corporate
TcLand Expression’s board of directors appoints highly qualified personalized medicine expert Felix Frueh PhD, as new board member
TcLand Expression, a leading company focused on gene expression biomarkers in immunology and personalized medicine today announced the appointment of Felix Frueh PhD, as new member of the company’s Board of Directors. EN. TcLand Expression SA, société leader dans le … Continue reading
TcLand Expression strengthens its senior management team by appointing Peter Payne as Chief Business Officer and Head of US Operations. TcLand Expression renforce son équipe dirigeante senior avec la nomination de Peter Payne en tant que Directeur du Business Développement … Continue reading
EPEMED, European personalized medicine Association organized its first conference in Paris. FR.
TcLand Expression appoints personalized medicine pioneer Patrick Terry as Chairman of the Board of Directors. EN. FR.